cbdMD Updates Director Equity Awards and Compensation Structure

cbdMD ( (YCBD) ) has shared an update.

On April 14, 2026, cbdMD, Inc. granted 1,572 restricted stock units to each independent director and its non-management employee director as compensation for the term beginning March 31, 2026, with the awards vesting quarterly through March 31, 2027 under the company’s 2025 Equity Compensation Plan. The board also revised its director pay structure by setting an annual cash retainer of $35,000 for independent directors and layering on additional fees for the board chair, key committee chairs, and committee members, signaling a formalized governance and compensation framework that may help the company recruit and retain experienced board members in a competitive market.

The most recent analyst rating on (YCBD) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on cbdMD stock, see the YCBD Stock Forecast page.

Spark’s Take on YCBD Stock

According to Spark, TipRanks’ AI Analyst, YCBD is a Neutral.

The score is held down primarily by weak financial performance (multi-year revenue decline, ongoing losses, and negative cash flow) and bearish technicals (price below key moving averages with negative MACD). The latest earnings call provides some offset via improving sequential sales, near-breakeven EBITDA, and strengthened liquidity, but margin pressure and regulatory risks remain.

To see Spark’s full report on YCBD stock, click here.

More about cbdMD

cbdMD, Inc. operates in the consumer wellness industry, focusing on cannabinoid-based products marketed to retail and online customers. The company typically uses equity-based incentives and cash compensation to attract and retain qualified directors and executives as part of its broader corporate governance and capital markets strategy.

Average Trading Volume: 934,388

Technical Sentiment Signal: Sell

Current Market Cap: $7.82M

Find detailed analytics on YCBD stock on TipRanks’ Stock Analysis page.